B6 (continued) Cancer (ICD code) Number of cases Rate (cases per 100,000) Male Female Male Female Total Lymphoid, haematopoietic and related tissue 480 360 840 15.4 9.8 12.3 (C81–C96, D45–D47) Hodgkin lymphoma (C81) 10 15 25 0.4 0.5 0.5 Non-Hodgkin lymphoma (C82–C85, C96) 140 108 248 4.7 3.0 3.8 Malignant immunoproliferative diseases (C88) 6 3 9 0.2 0.0 0.1 Multiple myeloma and malignant plasma cell 85 55 140 2.7 1.4 2.0 neoplasms (C90) Leukaemia (C91–C95) 181 132 313 5.8 3.9 4.7 Polycythaemia vera (D45) 4 4 8 0.1 0.1 0.1 Myelodysplastic syndromes (D46) 42 29 71 1.2 0.6 0.8 Lymphoid, haematopoietic and related tissue other 12 14 26 0.3 0.3 0.3 – neoplasms of uncertain or unknown behaviour (D47) Note: are expressed per 100,000 population and age-standardised to the WHO World Standard population. Source: New Zealand Mortality Collection Appendix C: Full text of the Cancer Registry Act 1993 1993 Cancer Registry No. 102 Title 1. Short Title and commencement 6. Director General may require supply of 2. Interpretation further information 3. Act to bind the Crown 7. Protection against actions 4. Maintenance of Cancer Registry 8. Offences 5. Reporting of cancer 9. Regulations 1993, No. 102 An Act to make better provision for the compilation of a statistical record of the incidence of cancer in its various to provide a basis for the better direction of programmes for research and for cancer prevention. BE IT ENACTED by the Parliament of New Zealand as follows: 1. Short Title and commencement (1) This Act may be as the Cancer Registry Act 1993. (2) This Act shall come into force on the 1st day of July 1994. In this Act, unless the context otherwise requires: 2. Interpretation – “Cancer”:
B6 (continued) Cancer (ICD code) Number of cases Rate (cases per 100,000) Male Female Male Female Total Lymphoid, haematopoietic and related tissue (C81–C96, D45–D47) 480 360 840 15.4 9.8 12.3 Hodgkin lymphoma (C81) 10 15 25 0.4 0.5 0.5 Non-Hodgkin lymphoma (C82–C85, C96) 140 108 248 4.7 3.0 3.8 Malignant immunoproliferative diseases (C88) 6 3 9 0.2 0.0 0.1 Multiple myeloma and malignant plasma cell neoplasms (C90) 85 55 140 2.7 1.4 2.0 Leukaemia (C91–C95) 181 132 313 5.8 3.9 4.7 Polycythaemia vera (D45) 4 4 8 0.1 0.1 0.1 Myelodysplastic syndromes (D46) 42 29 71 1.2 0.6 0.8 Lymphoid, haematopoietic and related tissue – other neoplasms of uncertain or unknown behaviour (D47) 12 14 26 0.3 0.3 0.3 Note: are expressed per 100,000 population and age-standardised to the WHO World Standard population. Source: New Zealand Mortality Collection Appendix C: Full text of the Cancer Registry Act 1993 1993 Cancer Registry No. 102 Title 1. Short Title and commencement 2. Interpretation 3. Act to bind the Crown 4. Maintenance of Cancer Registry 5. Reporting of cancer 6. Director General may require supply of further information 7. Protection against actions 8. Offences 9. Regulations 1993, No. 102 An Act to make better provision for the compilation of a statistical record of the incidence of cancer in its various to provide a basis for the better direction of programmes for research and for cancer prevention. BE IT ENACTED by the Parliament of New Zealand as follows: 1. Short Title and commencement (1) This Act may be as the Cancer Registry Act 1993. (2) This Act shall come into force on the 1st day of July 1994. 2. Interpretation – In this Act, unless the context otherwise requires: “Cancer”:
cancer-new-registrationsand-deaths-2012.docx